Technavio, a tech-focused market research firm, has published a new report on the global facial injectables market, which is expected to experience a moderate but steady growth rate with a CAGR of close to 10% during the forecast period.
This latest report by Technavio covers the market outlook and growth prospects of the global facial injectables market for 2016-2020, considering 2015 as the base year. In addition, an overview of the market, key leading countries, vendor landscape, and a detailed analysis of the top vendors operating in this market are covered in the report.
Based on geographical division, Technavio market researchers segment the global facial injectables market into the following key regions: The Americas, APAC, EMEA.
Geographical segmentation of the global facial injectables market for 2015 (market share %)
|
Americas |
49.69% |
|
EMEA |
33.13% |
|
APAC |
17.18% |
Source: Technavio
The Americas: largest revenue generating region for facial injectables
The global facial injectables market in the Americas generated revenues of almost $2 billion in 2015 and will grow at a CAGR of around 9% by 2020. The combination therapies for facial rejuvenation products encouraging consumers to adopt dermal filler products for facial aesthetic procedures are the primary driver for the American market. Various physicians are using Botox in combination with chemical peels and dermal fillers to improve facial rejuvenation outcomes and to prevent the formation of wrinkles, folds, and lines. The US and Latin American countries are contributing to high revenues in the region.
“The population of the Americas are opting for Botox, facial dermal fillers, and other facial aesthetics which has led to increased sales of facial injectables in the region. The economic development and growing disposable income in the region, especially in South America, will further fuel the market growth in the Americas. The presence of highly skilled physicians offering facial aesthetic procedures is aiding the sales and revenue of the market in the Americas,” says Barath Palada, a lead analyst at Technavio, specializing in research on orthopedics and general medical devices.
Click here to request a free sample of this report
Facial injectables market in EMEA
The global facial injectables market in EMEA generated revenues of around $1 billion in 2015 and will grow at a CAGR of around 10% by 2020. The rising awareness of facial injectable products will propel the growth of the market in the region. The UK, France, Dubai, Saudi Arabia, and Germany will emerge as the key revenue generator in the market during the forecast period. The growing popularity of medical tourism and the demand for non-invasive cosmetic procedures have a positive impact on dermal fillers in the EMEA market. The regulatory bodies in the area are implementing stringent rules to promote the safety of medical implants and prevent the entry of counterfeit products to encourage vendors to adopt good practices.
Facial injectables market in APAC
The global facial injectables market in APAC generated revenues of almost $1 billion in 2015 and will grow at a CAGR of about 13% by 2020. Leading vendors are investing in new facilities to tap new potential opportunities in the area, and the rising awareness about skin problems will help in the growth of the market in APAC. HA dermal filler treatments and fast-growing network of spas and beauty clinics in the APAC will lead to the development of the market. India and China are primary revenue contributors in the region. The vendors are investing in the development of non-invasive and low-cost anti-aging aesthetic treatments to attract more consumers and increase their profitability. Moreover, the demand for cosmetic surgeries will increase the implementation of Botox and facial dermal fillers by hospitals and surgical centers in the region.
The top leading vendors operating in the global facial injectables market are:
- Allergan
- Bloomega BioTechnology Corp
- Galderma
- Merz Aesthetics
Other prominent vendors in the market include AQTIS Medical, ColBar LifeScience, Hangzhou Techderm Biological Products, Laboratory Obvieline, Medytox, Polymekon, Qufu Guanglong Biochem, Revitacare, Suneva Medical, SciVision Biotech, Speciality European Pharma, Syneron, and Visionmed.
A more detailed analysis is available in the Technavio report titled, ‘Global Facial Injectables Market 2016-2020’. Technavio also customizes reports by other regions and specific segments upon request.
Other related reports:
- Global Plastic Surgery Products Market 2016-2020
- Global Cosmetic Surgery Market 2016-2020
- Global Plastic Surgery Products Market 2016-2020
To read more press releases- click here.
For any assistance or query, please contact our media team at:
media@technavio.com
US: +1 630 333 9501
UK: +44 208 123 1770
https://www.technavio.com/
